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Abstract 
The suppressor of cytokine signaling (SOCS) 
family of proteins are well known negative 
regulators of cytokine receptors signaling 
consisting of eight structurally similar proteins, 
SOCS1-7 and CIS. A key feature of this family of 
proteins is the presence of two structural motifs: a 
centrally located SH2 domain and a SOCS box in 
the C-terminus. The SOCS box mediates the 
interaction with the Elongins B and C complex 
while an additional motif mediates its interaction 
with Cullin 5 to assemble a Cullin/Ring ubiquitin 
ligase. In this complex SOCS6 acts as a substrate 
recognition subunit through interactions mediated 
by the N-terminus and the SH2 domain. SOCS6 
interacts with tyrosine kinase receptors FLT3 and c-
KIT and modulate their ubiquitination and function. 
Keywords 
CIS4; SSI4; CIS-4; SOCS4; STAI4; SOCS-4; 
SOCS-6; STATI4; HSPC060. 
Identity 
Other names: CIS-4, CIS4, HSPC060, SOCS-4, 
SOCS-6, SOCS4, SSI4, STAI4, STATI4 
HGNC (Hugo): SOCS6 
Location: 18q22.2 
DNA/RNA 
Description 
According to Entrez-Gene SOCS6 maps to 
NC_000018.10 in the region between 70288901 
and 70330199 on the plus strand. According to 
UCSC genome browser SOCS6 has two exons, one 
shorter of 190 base pairs and other on of 5656 base 
pairs. 
Transcription 
SOCS6 mRNA has 5864 nucleotides 
(NM_004232.3). The open reading frame (ORF) 
includes 1608 nucleotides situated in exon 2 
(Figure 1). Transcription is induced by activation of 
certain cytokine receptors and growth factor 
receptors. 
Pseudogene 
Chromosome 11q14.1 has a SOCS6 pseudogene in 
between 83789973 and 83791578 spanning 1606 
base pairs. The pseudogene has a 92% sequence 
similarity with the SOCS6 gene. 
 
Figure 1: SOCS6 mapped on Human Dec. 2013 (GRCh38/hg38) assembly in chromosome 18: (70288901-70330198) spanning 
41298 base pairs using UCSC Genome Browser. 
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Figure 2: Domain structure of SOCS6 protein, SB stand for SOCS-box. 
 
 
Protein 
Description 
SOCS6 gene is expressed as an approximately 60 
kDa protein with calculated isoelectric point 6.83 
and total charge -0.76 at pH 7.  
SOCS6 has a still uncharacterized long N-terminal 
region, an SH2 domain and a C-terminal SOCS-box 
(Figure 2).  
The protein is mainly expressed in the cytosol and 
associates with multiple proteins (Bayle et al., 
2004; Bayle et al., 2006; Hwang et al., 2007; Kazi 
et al., 2012; Zadjali et al., 2011).  
Most relevant for SOCS6 function is its capacity to 
associate with Elongin B and Elongin C and with 
Cullin 5 to assemble a functional E3 ubiquitin 
ligase complex. 
Expression 
SOCS6 is highly to moderately expressed in heart, 
parathyroid, salivary gland, stomach, thyroid, 
kidney and skeletal muscle tissues. Expression was 
also reported in mature hematopoietic cells and 
melanocyte. 
Localisation 
SOCS6 predominantly localizes to the cytosol and 
nucleus (Hwang et al., 2007). The N-terminal 
amino acids 1-210 influence its nuclear localization. 
Additionally SOCS6 localizes to the mitochondria 
and probably to the inner-surface of cell membrane 
(Lin et al., 2013). 
Function 
SOCS6 is involved in protein destabilization and to 
some extent acts as a signaling molecule. The 
presence of multiple domains in SOCS6 protein 
facilitates interaction with multiple signaling 
molecules. The SOCS6 SH2 domain associates 
with specific tyrosine phosphorylated proteins and 
the SOCS-box recruits the ubiquitin machinery 
directing proteins for degradation (Kazi et al., 2014; 
Zadjali et al., 2011). 
Homology 
Homologous proteins are found in various species 
including monkey, mouse, rat, frog and zebra fish 
etc. Monkey SOCS6 displays as high as 98% 
sequence similarity to human SOCS6, while zebra 
fish SOCS6 display 68% sequence similarity. In 
any case, the SOCS-box sequence is highly 
conserved and maintains a 100% sequence 
similarity. 
Mutations 
Note 
In the  COSMIC database 52 different SOCS6 
mutations have been listed, where 40 mutations are 
non-synonymous (figure 3), two mutations 
introduce stop codons at 199 and 328 sites, one 
mutation is reported as a 254A and 255G deletion 
and the other 9 mutations are synonymous 
mutations. 
Implicated in 
Hepatocellular carcinoma 
Note 
SOCS6 expression is significantly reduced in 
hepatocellular carcinoma and lower SOCS6 
correlates with overall and disease free survival 
(Qiu et al., 2013). 
Lung squamous cell carcinoma 
Note 
Loss of SOCS6 function is associated with poor 
prognosis in primary lung squamous cell 
carcinoma. Copy number loss and slight hyper-
methylation that was correlated with disease 
progression was reported in this disease (Sriram et 
al., 2012). 
 
 
Figure 3: Mutations in SOCS6 protein according to COSMIC database. 
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Prostate cancer 
Note 
The down-regulation of SOCS6 has been reported 
in prostate cancer tissues with a higher Gleason 
score, the advanced pathological stage, positive 
metastasis, and the positive PSA failure suggesting 
that SOCS6 might be associated with aggressive 
progression of prostate cancer (Zhu et al., 2013). 
Gastric cancer 
Note 
Loss of SOCS6 function has been reported in 
gastric cancer. Allelic loss and promoter hyper-
methylation occur in this cancer. Ectopic expression 
of SOCS6 led to reduced cell growth and colony 
formation of gastric cancer cell (Lai et al., 2010). 
Pancreatic cancer 
Note 
The microRNA miR-424-5p is a suppressor of 
SOCS6 expression. This microRNA is up-regulated 
in pancreatic cancer resulting in down-regulation of 
SOCS6 (Wu et al., 2013). Down-regulation of 
SOCS6 led to increased proliferation, migration and 
invasion of pancreatic cancer cells suggesting 
SOCS6 acts as a tumor suppressor in pancreatic 
cancer. 
Glucose metabolism 
Note 
SOCS6 has been shown to interact with the insulin 
receptor (INSR), INSR substrates IRS2 and IRS4, 
and negatively regulates insulin signaling (Krebs et 
al., 2002; Mooney et al., 2001). Although these 
findings suggest that SOCS6 might play a role in 
glucose metabolism, mice lacking SOCS6 gene did 
not display any significant defects in glucose 
metabolism apart from a slight growth retardation 
(Krebs et al., 2002). 
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